Abstract
The document associated with this DOI has been withdrawn.
Highlights
The paper is about medication-related osteonecrosis of the jaw (MRONJ) after administration of ipilimumab and a short literature review
The paper is well written and show relevant information for physicians and dentists about the risk of medication-related osteonecrosis of the jaw (MRONJ)
Summary
Review of: "New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): review of the literature and single-center experience."
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
